Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00581958 · ClinicalTrials.gov registry record
Radiation Biodosimetry in Patients Treated With Total Body Irradiation (TBI)
A clinical trial of Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 198
- Enrollment target
- 1
- Study location
NCT00581958: Completed study of Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00581958 is a study of Cancer that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 198 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00581958, a study of Cancer, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 198 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop blood tests and urine tests that can tell doctors how much radiation a person has been exposed to. Doctors know how much radiation patients are exposed to in certain medical situations. An example of this would be radiation treatment for cancer. Radiation treatment machines are programmed to give exact doses of radiation.
Primary Outcome
The approach involves profiling blood and urinary metabolites that are specific for radiation exposure and dose.
Conditions Studied
Interventions
- OTHER Blood Samples
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 198 participants |
| Start Date | 2007-11 |
| Est. Completion | 2018-10-31 |
What the finished NCT00581958 record still lists
NCT00581958 is an observational study that tracks outcomes without assigning an intervention. The registered 198 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Blood Samples is the first listed.
NCT00581958 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00581958 about?
NCT00581958 is a clinical study titled "Radiation Biodosimetry in Patients Treated With Total Body Irradiation (TBI)". The purpose of this study is to develop blood tests and urine tests that can tell doctors how much radiation a person has been exposed to. Doctors know how much radiation patients are exposed to in certain medical situations. An example of this would be radiation treatment for cancer. Radiation trea...
What is the current status of trial NCT00581958?
This trial is currently completed. The enrollment target is 198 participants. The study started on 2007-11. Estimated completion is 2018-10-31.
What conditions does trial NCT00581958 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT00581958?
The interventions under investigation include: Blood Samples (OTHER).
Who is sponsoring clinical trial NCT00581958?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00581958 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00581958's enrollment target sits among peer trials
198 237th of 615 higher than 379 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05203328 · 198 participants · NA
Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy
- NCT05426967 · 198 participants · NA
rTMS for Military TBI-related Depression
- NCT05561114 · 198 participants · Phase 3
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus
- NCT05585190 · 198 participants · NA
Stand Up for Your Health with a Sit-stand Desk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia